Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyNC Medicaid OTC Coverage Policy Update | OpenPayer
    Ask Trek AI about this page
    ModifiedCarolina Behavioral Health Alliance (CBHA) / NC MedicaidPolicy N/A

    NC Medicaid Over-The-Counter Products

    Customize your policy alerts

    Sign up for all carolinabehavioralhealth policy alerts

    Know when carolinabehavioralhealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of selected non-legend over-the-counter products and medications under the NC Medicaid and NC Health Choice pharmacy programs.

    Policy Summary
    PayerCarolina Behavioral Health Alliance (CBHA) / NC Medicaid
    PolicyNC Medicaid Over-The-Counter Products
    Policy CodePolicy N/A
    Change TypeModified
    Effective DateJuly 1, 2013
    Next Review DateN/A
    Key ActionProviders must consult the Medicaid and NCHC Preferred Drug List for applicable prior approval requirements.
    SourceLink
    POLICY UPDATE CHANGES

    Oral levonorgestrel contraceptives were added to the covered OTC products.

    Polyethylene glycol 3350 was added as a covered cathartic and laxative product.

    Syringes were added to the covered OTC product list.

    DHHS and NC Medicaid may change an OTC drug's coverage status when necessary.

    13Covered OTC product classes listed
    AnnualMinimum monitoring frequency
    3Candidate OTC coverage pathways
    4

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    General noncoverage triggers
    Under 21EPSDT exception age threshold

    Coverage Criteria

    General OTC Coverage

    Selected non-legend OTC products may be covered as an optional benefit for an NC Medicaid or NC Health Choice beneficiary within the pharmacy program when ALL of the following conditions are met.

    ALL of the following

    • The policy guidelines in Subsection 1.1 are met.
    • The product's therapeutic class code (GC3) is listed on the covered OTC product list in Attachment B.
    • The product is dispensed by a pharmacist pursuant to a lawful prescription.
    • For medications, the manufacturer has a valid rebate agreement with the Centers for Medicare and Medicaid Services.
    Covered OTC medications are subject to the same restrictions and recommendations as legend drugs. Prior authorization, quantity limits, and other outpatient pharmacy program policies may apply.

    Coverage Consideration

    Coverage of a specific OTC product or OTC medication is considered using ALL applicable decision factors below.

    Applicable coverage decision factors

    • The product provides cost-effective treatment or is a cost-effective alternative to a legend drug covered by Medicaid.
    • The cost savings or potential cost benefit of covering the OTC product supports coverage.
    • The recommendations of the North Carolina Physician Advisory Group (NCPAG) support coverage, including consideration of off-label indications using an evidence-based approach.
    • The limited ability of beneficiaries to pay out-of-pocket for relatively expensive OTC products is considered.
    NC Medicaid and the North Carolina Department of Health and Human Services may change an OTC drug's coverage status because of urgent patient safety concerns, medication access issues, or significant financial implications. Changes are communicated to the Pharmacy and Therapeutics (P&T) Committee by email when the change is made and presented at the next scheduled P&T Committee meeting and subsequent Physicians' Advisory Group meeting.

    EPSDT Exception for Medicaid Beneficiaries Under 21

    For a Medicaid beneficiary under 21 years of age, EPSDT may allow limitations in this policy to be exceeded or not apply when the requested product is medically necessary under federal EPSDT requirements.

    EPSDT exception requirements

    • The beneficiary is enrolled in Medicaid and is under 21 years of age.
    • The requested product is medically necessary health care to correct or ameliorate a defect, physical or mental illness, or condition identified through a screening examination, including an evaluation by a physician or other licensed practitioner.
    • Provider documentation explains how the product meets all EPSDT criteria, including correcting, improving, or maintaining the beneficiary's health in the best condition possible; compensating for a health problem; preventing the problem from worsening; or preventing the development of additional health problems.
    • The service is provided in the most economic mode, as long as the treatment made available is similarly efficacious to the service requested by the beneficiary's physician, therapist, or other licensed practitioner.

    General Medical Necessity Criteria

    Medicaid and NCHC cover a procedure, product, or service related to this policy only when it is medically necessary and ALL of the following general criteria are met.

    ALL required general criteria

    • The procedure, product, or service is individualized, specific, and consistent with symptoms or a confirmed diagnosis of the illness or injury under treatment, and is not in excess of the beneficiary's needs.
    • The procedure, product, or service can be safely furnished, and no equally effective and more conservative or less costly treatment is available statewide.
    • The procedure, product, or service is furnished in a manner not primarily intended for the convenience of the beneficiary, the beneficiary's caretaker, or the provider.

    Identification of Candidate OTCs

    A drug may be considered as a candidate for OTC coverage when ANY of the following criteria apply.

    ANY of the following

    • A Medicaid-covered legend drug is FDA-approved as an OTC drug and results in significant cost savings to Medicaid. Example: an OTC version of Prilosec that is identical in strength and formulation.
    • An efficacious drug is available only as OTC and not as a legend drug, and all other legend treatments are significantly more expensive without a significant increase in effectiveness.
    • Coverage of an OTC product or group of OTC products expands treatment options because the products have been shown to decrease the total cost of care for certain conditions, such as allergy treatments.

    OTC Program Management

    OTC program management includes evaluation before statewide availability, annual monitoring, and continued-list management.

    OTC program management

    • When the effect of adding an OTC is uncertain in terms of utilization, cost savings, or other factors, limited pilot studies are recommended and may be conducted in venues such as Community Care of North Carolina demonstration projects before the OTC is made available statewide.
    • Each product on the OTC list is monitored at least annually to assess total utilization, per-member-per-month rates, use rates, and the cost effectiveness of continuing to include the OTC on the list.
    • Upon the advice of NCPAG, NC Medicaid may remove an OTC product from the covered OTC list if it fails to meet criteria for continued coverage under the pharmacy benefit. Removal information is posted to the OTC list according to NC Medicaid clinical coverage policy guidelines.

    Covered OTC Products

    Coverage requires that the product's therapeutic class code (GC3) be included on the covered OTC product list. The listed beginning dates identify the applicable coverage start dates; no ending date is shown for the products below.

    Covered OTC product list

    • Smoking deterrent agents (nicotine) — GC3 J3A; beginning date 07/20/2005.
    • Proton pump inhibitors — GC3 D4J; beginning date 10/01/2003.
    • Second generation antihistamines — GC3 Z2Q; beginning date 11/25/2003.
    • Second generation antihistamines—decongestant combination products — GC3 Z2O; beginning date 09/15/2010; quantity limits apply.
    • Insulins — GC3 C4G; beginning date 06/25/1991.

    EPSDT does not require the state Medicaid agency to provide any service, product, or procedure that is unsafe, ineffective, experimental, or investigational, or that is not medical in nature or not generally recognized as an accepted method of medical practice or treatment.

    EPSDT does not apply to NCHC beneficiaries. For an NCHC beneficiary age 6 through 18, NC Medicaid shall deny coverage unless the beneficiary meets the criteria in Section 3.0. Only services included under the NCHC State Plan and NC Medicaid clinical coverage policies, service definitions, or billing codes are covered.

    Medicaid and NCHC do not cover a procedure, product, or service that duplicates another provider's procedure, product, or service.

    Medicaid and NCHC do not cover a procedure, product, or service that is experimental, investigational, or part of a clinical trial.

    If an OTC product is not covered by the Medicaid program, it is not covered under the NCHC program.

    For NCHC beneficiaries, coverage does not include long-term care services, nonemergency medical transportation, or EPSDT. Dental services are provided only on a restricted basis according to criteria adopted by the Department.

    Covered OTC Product Coding

    Covered Over-the-Counter ProductsmixedCovered
    J3ASmoking deterrent agents (nicotine)
    D4JProton pump inhibitors
    Z2QSecond generation antihistamines
    Z2OSecond generation antihistamines- decongestant combination products (Quantity limits apply)
    C4GInsulins
    X2BSyringes
    M4ATest Strips
    Y9AControl Solution
    Y3ALancets
    Y9ALancing Device
    1–10 of 13
    1/2

    Provider Requirements and Denial Risks

    Prior Authorization

    Prior Approval May Apply

    Covered OTC medications are subject to the same restrictions and recommendations as legend drugs. Prior approval and quantity limits may apply, and all outpatient pharmacy program policies remain applicable.

    • Check whether prior approval is required before dispensing or billing.
    Prior Authorization

    Check the Preferred Drug List

    Check the Medicaid and NCHC Preferred Drug Lists for current prior approval requirements before providing or billing for the product.

    • Use the Preferred Drug List available through NC Medicaid at https://medicaid.ncdhhs.gov/.

    Unsupported block type: billing_rule

    Policy Background

    The policy permits coverage of selected OTC products and medications when they provide cost-effective treatment or a cost-effective alternative to a covered legend drug. Coverage decisions may consider cost savings or potential cost benefit, evidence-based recommendations from the North Carolina Physician Advisory Group—including appropriate off-label indications—and beneficiaries' limited ability to pay for relatively expensive OTC products.

    Quantity Limits

    Quantity Limits
    Product classSecond generation antihistamine-decongestant combination products
    GC3 codeZ2O
    Quantity limitQuantity limits apply
    Beginning date of coverage09/15/2010
    Policy Summary
    PayerCarolina Behavioral Health Alliance (CBHA) / NC Medicaid
    PolicyNC Medicaid Over-The-Counter Products
    Policy CodePolicy N/A
    Change TypeModified
    Effective DateJuly 1, 2013
    Next Review DateN/A
    Key ActionProviders must consult the Medicaid and NCHC Preferred Drug List for applicable prior approval requirements.
    SourceLink
    On This Page
    Coverage CriteriaCovered OTC Product CodingProvider Requirements and Denial RisksPolicy BackgroundQuantity Limits
  1. The determination process does not delay delivery of the needed service and does not limit the beneficiary's right to a free choice of providers.
  2. If the product requires prior approval, the beneficiary's age does not eliminate the prior approval requirement.
  3. Additional EPSDT and prior approval information is available in the NCTracks Provider Claims and Billing Assistance Guide (https://www.nctracks.nc.gov/content/public/providers/providermanuals.html) and on the EPSDT provider page (https://medicaid.ncdhhs.gov/).
    Syringes — GC3 X2B; beginning date 07/17/2009.
  4. Test strips — GC3 M4A; beginning date 11/15/2009.
  5. Control solution — GC3 Y9A; beginning date 11/15/2009.
  6. Lancets — GC3 Y3A; beginning date 11/15/2009.
  7. Lancing device — GC3 Y9A; beginning date 11/15/2009.
  8. Pen needles — GC3 X2A; beginning date 02/26/2010.
  9. Oral contraceptives (levonorgestrel) — GC3 G8A; beginning date 07/01/2017.
  10. Cathartics and laxatives, limited to polyethylene glycol 3350 — GC3 D6S; beginning date 12/01/2018.
  11. Documentation Required

    Document EPSDT Medical Necessity

    For a Medicaid beneficiary under age 21, service limitations may be exceeded only when provider documentation demonstrates that the requested product is medically necessary under EPSDT and meets all applicable EPSDT criteria.

    • Document how the product will correct or ameliorate a defect, illness, or condition; improve, maintain, or compensate for the beneficiary's health problem; prevent worsening; or prevent additional health problems.
    • EPSDT does not eliminate a prior approval requirement when prior approval is required.
    Documentation Required

    Support Medical Necessity

    Support medical-necessity determinations with documentation showing that the product is individualized, specific, and consistent with the beneficiary's symptoms or confirmed diagnosis, is not excessive for the beneficiary's needs, can be safely furnished, and is not primarily for convenience.

    • Document why no equally effective, more conservative, or less costly statewide treatment is available.

    Unsupported block type: billing_rule

    Unsupported block type: billing_rule

    Unsupported block type: billing_rule

    Unsupported block type: billing_rule

    Denial Risk

    Meet Product and Dispensing Requirements

    Claims may be denied when OTC product requirements are not met, including when the therapeutic class code (GC3) is not listed on the Covered Over-the-Counter Products list, the product is not dispensed by a pharmacist pursuant to a lawful prescription, or a medication manufacturer lacks a valid CMS rebate agreement.

    • Confirm the product is listed and all dispensing, prescription, and manufacturer rebate requirements are satisfied before billing.
    Denial Risk

    Meet Eligibility and Program Criteria

    Claims may be denied when the beneficiary is not eligible on the date of service, is not enrolled in Medicaid or NCHC, has an applicable eligibility restriction, or does not meet program criteria such as NCHC age requirements.

    • Confirm eligibility and enrollment for every service date.
    • Confirm all applicable Section 2.0 eligibility requirements.
    Denial Risk

    EPSDT Exclusions Apply

    EPSDT does not require coverage of a service, product, or procedure that is unsafe, ineffective, experimental, investigational, not medical in nature, or not generally recognized as an accepted method of medical practice or treatment.

    • EPSDT coverage also requires medical necessity under the applicable federal standard.
    Denial Risk

    General Noncoverage Conditions

    Medicaid and NCHC may deny coverage when eligibility or Section 3.0 coverage criteria are not met, when the product or service duplicates another provider's service, or when it is experimental, investigational, or part of a clinical trial.

    • Confirm the product is medically necessary, safely furnished, and not primarily for convenience.
    Denial Risk

    Medicaid Coverage Required for NCHC

    An OTC product that is not covered under the Medicaid program is not covered under the NCHC program. Confirm Medicaid coverage before billing an NCHC beneficiary.

    • Medicaid coverage is a prerequisite for NCHC coverage of the OTC product.
    Denial Risk

    Apply NCHC-Specific Limitations

    NCHC coverage is limited to services included under the NCHC State Plan and applicable NC Medicaid clinical coverage policies, service definitions, or billing codes. Claims may be denied when Section 3.0 criteria or NCHC-specific restrictions are not met.

    • NCHC does not provide EPSDT.
    • NCHC-specific exclusions also include long-term care and nonemergency medical transportation; dental services are restricted under applicable criteria.